Croissance 32nd Annual Report; loan-to-equity conversion proposal

Revenue Growth 20pctPat Growth 25pctAuditor Mid Year ChangeResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.7%Reaction day

₹1.16

prior close

₹1.14

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-1.6% vs market

Residential, Commercial Projects peers, median of 67sector-0.1%-1.6% vs sector

On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 1.6 pts less than its Residential, Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.7-0.2-1.6-0.1-1.6

Next day

+0.0-0.3+0.3-1.2+1.2

+0.9-0.2+1.1-0.2+1.0

-6.0-3.5-2.5-1.4-4.6

-3.4-3.6+0.2-2.4-1.1

-6.0-2.8-3.2-1.3-4.8

-7.8-1.4-6.4-2.3-5.5

15d

-11.2-3.0-8.2-3.3-7.9

-15.5-4.4-11.1-3.5-12.0

—————

UpDownMarket · Nifty Microcap 250Sector · Residential, Commercial Projects peers, median of 67Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Croissance Limited filed its 32nd Annual Report for FY 2025-26. Revenue rose from Rs 10.47 lakh to Rs 60.68 lakh, with standalone PAT up from Rs 0.34 lakh to Rs 5.43 lakh. Objects clause altered to include agriculture and green energy. AGM on Sep 30, 2026 will seek approval for converting loans up to Rs 1000 crore into equity shares and appoint new auditor M G S Reddy and Co, replacing resigned YCRJ and Associates.

Likely market impact

Strong revenue and profit growth. Loan-to-equity conversion option may dilute shareholders if exercised. Auditor change noted.